Literature DB >> 31409674

Hypertension is a modifiable risk factor for osteonecrosis in acute lymphoblastic leukemia.

Laura J Janke1, Sara L Van Driest2, Mary V Portera3, Ravi V Atreya4, Joshua C Denny4,5, Deqing Pei6, Cheng Cheng6, Sue C Kaste7, Hiroto Inaba8, Sima Jeha8, Ching-Hon Pui8, Mary V Relling3, Seth E Karol8.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31409674      PMCID： PMC6753622          DOI： 10.1182/blood.2019000006

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  21 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

2.  Vascular hypertrophy and remodeling in secondary hypertension.

Authors:  D Rizzoni; E Porteri; M Castellano; G Bettoni; M L Muiesan; P Muiesan; S M Giulini; E Agabiti-Rosei
Journal:  Hypertension       Date:  1996-11       Impact factor: 10.190

3.  Steroid-induced Hypertension During Induction Chemotherapy for Acute Lymphoblastic Leukemia in US Children's Hospitals.

Authors:  Ian Bakk; Terah Koch; Joseph Stanek; Sarah H O'Brien; Suzanne Reed
Journal:  J Pediatr Hematol Oncol       Date:  2018-01       Impact factor: 1.289

4.  Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial.

Authors:  Leonard A Mattano; Meenakshi Devidas; James B Nachman; Harland N Sather; Stephen P Hunger; Peter G Steinherz; Paul S Gaynon; Nita L Seibel
Journal:  Lancet Oncol       Date:  2012-08-15       Impact factor: 41.316

5.  Utility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoids.

Authors:  Sue C Kaste; Deqing Pei; Cheng Cheng; Michael D Neel; W Paul Bowman; Raul C Ribeiro; Monika L Metzger; Deepa Bhojwani; Hiroto Inaba; Patrick Campbell; Jeffrey E Rubnitz; Sima Jeha; John T Sandlund; James R Downing; Mary V Relling; Ching-Hon Pui; Scott C Howard
Journal:  J Clin Oncol       Date:  2015-01-20       Impact factor: 44.544

6.  High incidence of avascular necrosis in adolescents with acute lymphoblastic leukaemia: a UKALL XII analysis.

Authors:  B Patel; S M Richards; J M Rowe; A H Goldstone; A K Fielding
Journal:  Leukemia       Date:  2007-11-08       Impact factor: 11.528

Review 7.  The effects of hypertension on the cerebral circulation.

Authors:  Paulo W Pires; Carla M Dams Ramos; Nusrat Matin; Anne M Dorrance
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-12       Impact factor: 4.733

8.  Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer Institute ALL Consortium Protocol 00-01.

Authors:  Lynda M Vrooman; Kristen E Stevenson; Jeffrey G Supko; Jane O'Brien; Suzanne E Dahlberg; Barbara L Asselin; Uma H Athale; Luis A Clavell; Kara M Kelly; Jeffery L Kutok; Caroline Laverdière; Steven E Lipshultz; Bruno Michon; Marshall Schorin; Mary V Relling; Harvey J Cohen; Donna S Neuberg; Stephen E Sallan; Lewis B Silverman
Journal:  J Clin Oncol       Date:  2013-01-28       Impact factor: 44.544

9.  Genetic predictors of glucocorticoid-induced hypertension in children with acute lymphoblastic leukemia.

Authors:  Landry K Kamdem; Leo Hamilton; Cheng Cheng; Wei Liu; Wenjian Yang; Julie A Johnson; Ching-Hon Pui; Mary V Relling
Journal:  Pharmacogenet Genomics       Date:  2008-06       Impact factor: 2.089

10.  Treating childhood acute lymphoblastic leukemia without cranial irradiation.

Authors:  Ching-Hon Pui; Dario Campana; Deqing Pei; W Paul Bowman; John T Sandlund; Sue C Kaste; Raul C Ribeiro; Jeffrey E Rubnitz; Susana C Raimondi; Mihaela Onciu; Elaine Coustan-Smith; Larry E Kun; Sima Jeha; Cheng Cheng; Scott C Howard; Vickey Simmons; Amy Bayles; Monika L Metzger; James M Boyett; Wing Leung; Rupert Handgretinger; James R Downing; William E Evans; Mary V Relling
Journal:  N Engl J Med       Date:  2009-06-25       Impact factor: 91.245
View more
  6 in total

Review 1.  Pharmacogenomics and ALL treatment: How to optimize therapy.

Authors:  Seth E Karol; Jun J Yang
Journal:  Semin Hematol       Date:  2020-10-20       Impact factor: 3.851

Review 2.  [Osteonecrosis-severe side effect of treatment for acute lymphoblastic leukemia].

Authors:  Michaela Kuhlen; Marina Kunstreich; Nicola Gökbuget; Gabriele Escherich
Journal:  Orthopadie (Heidelb)       Date:  2022-09-07

Review 3.  Osteonecrosis in Adults With Acute Lymphoblastic Leukemia: An Unmet Clinical Need.

Authors:  Michaela Kuhlen; Marina Kunstreich; Nicola Gökbuget
Journal:  Hemasphere       Date:  2021-03-09

Review 4.  Hypertension in Pediatric Acute Lymphoblastic Leukemia Patients: Prevalence, Impact, and Management Strategies.

Authors:  Lindsey Murphy; Kelly Maloney; Lia Gore; Eliza Blanchette
Journal:  Integr Blood Press Control       Date:  2022-01-19

Review 5.  Recent perspectives on the association between osteonecrosis and bone mineral density decline in childhood acute lymphoblastic leukemia.

Authors:  Jenneke E van Atteveld; Demi Tc de Winter; Rob Pieters; Sebastian Jcmm Neggers; Marry M van den Heuvel-Eibrink
Journal:  Fac Rev       Date:  2021-06-23

6.  Effects of zoledronic acid on osteonecrosis and acute lymphoblastic leukemia treatment efficacy in preclinical models.

Authors:  Laura J Janke; Jieun Kim; Monique A Payton; David A Jenkins; Xiangjun Cai; Emily R Finch; Yiwei Liu; Mary V Relling; Seth E Karol
Journal:  Pediatr Blood Cancer       Date:  2021-06-14       Impact factor: 3.838
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.